DAIC

APRIL 24, 2024

Blood clots are the third most common vascular disease. Almost one million patients suffer from peripheral blood clots that must be treated each year, and up to 33% of them suffer long-term complications, according to the Center for Disease Control.

Blood Clot 111

Blood Clot Innovation Technology Outcomes 111

DAIC

MARCH 24, 2025

The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated. Bennet George, Interventional Cardiologist at Vital Heart & Vein in Houston, Texas.

Blood Clot 52

Blood Clot Vascular Care Technology Thrombosis 52

DAIC

APRIL 4, 2024

With the integration of Osso VR's immersive technology and the expertise of the ACC, interventionalists will gain access to a state-of-the-art training simulation of the workflow and skills required to successfully perform a left atrial appendage occlusion procedure (LAAO). and globally."

Blood Clot 107

Blood Clot Innovation Education Technology 107

DAIC

JUNE 12, 2024

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges. “Duo

Stents 105

Stents Stent Anatomy Ultrasound 105

SoftCath

JUNE 20, 2021

The acceleration in technological innovation has brought a significant transformation in the medical device industry. Some of the ruling trends and technologies of ruling the imaging market as of now are as follows: Computed Tomography (CT) CT scan has become a common phrase in our lives now. Billion in 2020.

Technology 52

Technology Cancer COVID-19 Blood Clot 52

DAIC

MARCH 8, 2024

million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. Through a new four-year, $7.8

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs).

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105